Wolverine Trading’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-37,079
| Closed | -$1.42M | – | 5076 |
|
|
2025
Q1 | $1.44M | Buy |
37,079
+25,205
| +212% | +$923K | ﹤0.01% | 1909 |
|
|
2024
Q4 | $400K | Buy |
+11,874
| New | +$427K | ﹤0.01% | 3670 |
|
|
2024
Q2 | – | Sell |
-12,510
| Closed | -$536K | – | 4768 |
|
|
2024
Q1 | $536K | Buy |
12,510
+5,686
| +83% | +$234K | ﹤0.01% | 2775 |
|
|
2023
Q4 | $253K | Sell |
6,824
-18,423
| -73% | -$661K | ﹤0.01% | 3632 |
|
|
2023
Q3 | $915K | Buy |
+25,247
| New | +$896K | ﹤0.01% | 2171 |
|
|
2023
Q2 | – | Sell |
-8,884
| Closed | -$319K | – | 4512 |
|
|
2023
Q1 | $313K | Sell |
8,884
-13,699
| -61% | -$479K | ﹤0.01% | 2974 |
|
|
2022
Q4 | $794K | Sell |
22,583
-38,111
| -63% | -$1.27M | ﹤0.01% | 2001 |
|
|
2022
Q3 | $1.78M | Buy |
+60,694
| New | +$2.3M | ﹤0.01% | 1500 |
|
|
2022
Q2 | – | Sell |
-15,613
| Closed | -$853K | – | 4986 |
|
|
2022
Q1 | $853K | Sell |
15,613
-46,233
| -75% | -$2.51M | ﹤0.01% | 2620 |
|
|
2021
Q4 | $3.41M | Buy |
61,846
+34,982
| +130% | +$1.82M | ﹤0.01% | 1411 |
|
|
2021
Q3 | $1.29M | Buy |
26,864
+6,137
| +30% | +$308K | ﹤0.01% | 2669 |
|
|
2021
Q2 | $1.03M | Buy |
20,727
+10,823
| +109% | +$520K | ﹤0.01% | 2749 |
|
|
2021
Q1 | $450K | Sell |
9,904
-33,379
| -77% | -$1.52M | ﹤0.01% | 3859 |
|
|
2020
Q4 | $2M | Buy |
43,283
+7,719
| +22% | +$355K | ﹤0.01% | 1695 |
|
|
2020
Q3 | $1.66M | Buy |
35,564
+6,315
| +22% | +$316K | ﹤0.01% | 1618 |
|
|
2020
Q2 | $1.49M | Sell |
29,249
-22,535
| -44% | -$1.16M | ﹤0.01% | 1632 |
|
|
2020
Q1 | $2.43M | Buy |
51,784
+34,318
| +196% | +$1.83M | 0.01% | 1194 |
|
|
2019
Q4 | $1.03M | Buy |
+17,466
| New | +$972K | ﹤0.01% | 2383 |
|
|
2019
Q3 | – | Sell |
-38,164
| Closed | -$1.96M | – | 4593 |
|
|
2019
Q2 | $1.91M | Sell |
38,164
-25,584
| -40% | -$1.28M | 0.01% | 1536 |
|
|
2019
Q1 | $3.33M | Buy |
63,748
+32,344
| +103% | +$1.62M | 0.01% | 1139 |
|
|
2018
Q4 | $1.5M | Sell |
31,404
-10,728
| -25% | -$528K | ﹤0.01% | 1645 |
|
|
2018
Q3 | $2.12M | Buy |
+42,132
| New | +$2.14M | ﹤0.01% | 1620 |
|
|
2018
Q1 | – | Sell |
-12,910
| Closed | -$601K | – | 5364 |
|
|
2017
Q4 | $572K | Buy |
12,910
+7,439
| +136% | +$344K | ﹤0.01% | 2839 |
|
|
2017
Q3 | $278K | Buy |
5,471
+106
| +2% | +$5.38K | ﹤0.01% | 3365 |
|
|
2017
Q2 | $290K | Sell |
5,365
-9,522
| -64% | -$508K | ﹤0.01% | 3091 |
|
|
2017
Q1 | $791K | Sell |
14,887
-10,845
| -42% | -$550K | ﹤0.01% | 1930 |
|
|
2016
Q4 | $1.24M | Buy |
25,732
+2,182
| +9% | +$108K | 0.01% | 1719 |
|
|
2016
Q3 | $1.26M | Sell |
23,550
-31,228
| -57% | -$1.71M | 0.01% | 1651 |
|
|
2016
Q2 | $2.91M | Buy |
+54,778
| New | +$2.89M | 0.02% | 884 |
|
Other funds holding GSK
JEST
Wolverine Trading's GSK Position: Q2 2025 in Review
Wolverine Trading sold out of GSK (GSK) in Q2 2025, closing a stake of 37,079 shares — an estimated $1.42M sold.
Wolverine Trading first reported a position in GSK in Q2 2016 and held it in 29 quarters. The position peaked at $3.41M in Q4 2021. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.
- Wolverine Trading reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
- Wolverine Trading sold 37,079 GSK shares in Q2 2025, an estimated $1.42M.
- Wolverine Trading first reported a position in GSK in Q2 2016 and held it in 29 quarters.
- Wolverine Trading's GSK position peaked at $3.41M in Q4 2021.
- 890 funds tracked by Wall St. Rank held GSK as of Q2 2025.
Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.